DBV Technologies S.A(NASDAQ:DBVT) 
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergie...
Website: http://www.dbv-technologies.com
Founded: 2002
Full Time Employees: 311
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-03
P
O 7.55
H 8.48
L 7.26
C 7.86
V 130,829
10EMA 7.86
20EMA 7.86
60EMA 7.86
120EMA 7.86
250EMA 7.86